LATEST ARTICLES

Autoscribe Informatics Appoints Claude Hatfield As President Of North American Operations

Autoscribe Informatics, a leading provider of Laboratory Information Management Systems (LIMS), has appointed Claude Hatfield as President of North American Operations. Claude assumes responsibility for leading the North American operation to achieve its revenue, profit and cashflow objectives while encouraging global...
video

Reactions Video: Can You Cryogenically Freeze Your Body And Come Back To Life?

When you die, many things can be done with your body -- embalming, cremation, donation to science and so on. But some people will choose to have their dead bodies, or parts thereof, frozen until technology has advanced enough to...

Eliminating Helicobacter Pylori Reduced Risk Of Gastric Cancer By 75% In An American Population

In a new study published in the journal Gastroenterology, researchers in the Perelman School of Medicine at the University of Pennsylvania have found, after analyzing records of close to 400,000 patients, that successfully eliminating Helicobacter pylori from...

CRISPR Therapeutics And Vertex Release Interim Phase I Data On CRISPR/Cas9 Gene-Editing Therapy

CRISPR Therapeutics and Vertex Pharmaceuticals Incorporated have announced positive, interim data from the first two patients with severe hemoglobinopathies treated with the investigational CRISPR/Cas9 gene-editing therapy CTX001 in ongoing Phase 1/2 clinical trials. One patient with transfusion-dependent beta thalassemia (TDT) received...

Apple Women’s Health Large-Scale Longitudinal Study Launched

Harvard T.H. Chan School of Public Health, Apple, and the National Institutes of Health (NIH) has launched the Apple Women’s Health Study, a large-scale longitudinal study led by a team of researchers at Harvard Chan School that aims to advance...

Multiple Cis Mutations Of PIK3CA Frequent In Cancer And Associated With Treatment Response

A new paper in Science magazine reports that double mutations of PIK3CA on the same allele (cis) are more common than previously thought with 12-15% of breast cancers and other tumor types harboring these cis mutations. Sequencing...

Centogene And PTC Therapeutics Collaborate To Deliver A Diagnostic Program For AADC Deficiency

CENTOGENE N.V., a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies, has signed an agreement with PTC Therapeutics, Inc. (PTC) for a global diagnostic program for aromatic...

MedGenome Selects Applied Biosystems™ Axiom™ Platform For South Asian Research Genotyping

MedGenome, a global leader in personalized medicine, has developed a proprietary genotyping array to efficiently enable large-scale genetic studies focused on South Asian populations. The South Asian Research Genotyping Array by MedGenome ("SARGAM") will be optimized for capturing the unique variants...

Celyad’s Off-The-Shelf Cell Therapy CYAD-101 In Colorectal Cancer Dose-Escalation Phase 1 Trial

Celyad, a clinical-stage biopharmaceutical company focused on the development of CAR-T cell therapies, has announced highlights from the company’s NKG2D-based CAR-T clinical candidates for the treatment of metastatic colorectal cancer (mCRC), including its novel, off-the-shelf cell therapy CYAD-101 and alloSHRINK dose-escalation...

Glaucoma And Brain Degeneration Linked In People With African Ancestry

A global research team led by scientists from Singapore and the United States has discovered new evidence that there is an underlying link between degeneration of the eye and brain. They found that genetic variation at a beta-amyloid gene was...